| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |